Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
As of 11 June 2026, the MHRA approved the semaglutide (Wegovy) tablet as the first GLP-1 receptor agonist tablet licensed for weight loss and weight management in the UK
FAQs AOD9604 What is AOD9604
These tests are simple and can identify problems with straightforward solutions
The semaglutide injection benefits include less frequent dosing and improved adherence
Semaglutide Semaglutide belongs to a class of medication called GLP-1
US$ 28.48
US$ 29.30
US$ 26.85
US$ 23.88
US$ 27.25
US$ 27.93
US$ 22.93
US$ 22.57
US$ 24.98
US$ 28.35
US$ 28.37
US$ 28.59
